Clinical Efficacy Is Sustained in Relapsing Remitting Multiple Sclerosis Following Treatment Switch to Placebo from Cladribine Tablets in Patients with High Disease Activity at Baseline

P. Vermersch, G. Giovannoni, P. Soelberg-sorensen, B. Keller, D. Jack